Dyne Therapeutics Ownership | Who Owns Dyne Therapeutics?


OverviewForecastRevenueFinancialsChart

Dyne Therapeutics Ownership Summary


Dyne Therapeutics is owned by 111.02% institutional investors, 0.48% insiders. Atlas venture life science advisors is the largest institutional shareholder, holding 9.90% of DYN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.59% of its assets in Dyne Therapeutics shares.

DYN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDyne Therapeutics111.02%0.48%-11.50%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Atlas venture life science advisors8.02M9.90%$283.03M
Fcpm iii services b.v.7.85M9.68%$276.86M
Blackrock7.39M9.11%$260.69M
Rtw investments, lp6.39M7.88%$225.40M
Ra capital management6.05M7.46%$213.48M
Fmr5.32M6.56%$187.71M
Vanguard group4.72M5.82%$166.50M
Janus henderson group4.62M5.71%$163.24M
Deep track capital, lp4.00M4.94%$141.16M
Adage capital partners gp3.33M4.11%$117.45M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.7.85M40.83%$276.86M
Mpm asset management1.56M30.26%$55.11M
Atlas venture life science advisors8.02M29.80%$283.03M
Vida ventures advisors407.50K15.73%$14.38M
Tcg crossover management2.65M9.75%$93.52M
Octagon capital advisors lp1.18M6.55%$41.67M
Acuta capital partners212.50K6.32%$7.50M
Vivo capital1.64M5.33%$57.70M
Vr adviser2.17M4.89%$76.72M
Deep track capital, lp4.00M4.21%$141.16M

Top Buyers

HolderShares% AssetsChange
Rtw investments, lp6.39M3.49%3.30M
Fmr5.32M0.01%2.10M
Holocene advisors, lp2.08M0.31%2.08M
Blackrock7.39M0.01%2.00M
Janus henderson group4.62M0.09%1.95M

Top Sellers

HolderShares% AssetsChange
Mpm asset management1.56M30.26%-1.89M
Logos global management lp265.00K0.75%-1.47M
State street3.20M0.00%-992.58K
Deep track capital, lp4.00M4.21%-555.38K
Lmr partners llp---477.00K

New Positions

HolderShares% AssetsChangeValue
Holocene advisors, lp2.08M0.31%2.08M$73.27M
Eventide asset management485.00K0.29%485.00K$17.12M
Pictet asset management sa294.75K0.01%294.75K$10.40M
Soleus capital management201.00K0.63%201.00K$7.09M
Avoro capital advisors115.75K0.05%115.75K$4.08M

Sold Out

HolderChange
Headlands-1.00
Nelson, van denburg & campbell wealth management group-9.00
Innealta capital-81.00
Adar1 capital management-297.00
Truvestments capital-464.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242075.08%111,994,7580.90%1110.59%117-7.14%5417.39%
Jun 30, 202419712.57%110,993,40616.43%1360.99%126-1.56%4658.62%
Mar 31, 202417528.68%95,333,55236.34%1170.91%12885.51%29-27.50%
Dec 31, 202313613.33%69,922,23416.75%1131.19%6916.95%4025.00%
Sep 30, 2023120-59,888,8411.18%981.00%59-18.06%3214.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.64M2.59%-13.39K
iShares Russell 2000 ETF2.27M2.23%-4.75K
Fidelity Growth Compy Commingled Pl S1.80M1.79%14.65K
Fidelity Growth Compy Commingled Pl O1.79M1.78%348.61K
SPDR® S&P Biotech ETF1.81M1.78%-54.90K
Janus Henderson Global Life Sciences1.42M1.42%227.22K
Janus Henderson Global Life Sciences D1.42M1.40%273.25K
Fidelity Growth Company Fund1.33M1.33%12.87K
Vanguard Institutional Extnd Mkt Idx Tr1.17M1.15%-4.31K
Janus Henderson Glb Life Scn I2 USD1.09M1.07%31.93K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 11, 2024Beskrovnaya Oxana Chief Scientific OfficerSell$65.63K
Dec 11, 2024Scalzo Richard William SVP, Head of Finance & Admin.Sell$40.91K
Dec 09, 2024Kersten Dirk-Sell$1.00M
Dec 06, 2024Kersten Dirk-Sell$2.98M
Dec 05, 2024Kersten Dirk-Sell$110.56K

Insider Transactions Trends


DateBuySell
2024 Q4-24
2024 Q3279
2024 Q2-26
2024 Q12122
2023 Q4-11

DYN Ownership FAQ


Who Owns Dyne Therapeutics?

Dyne Therapeutics shareholders are primarily institutional investors at 111.02%, followed by 0.48% insiders and -11.50% retail investors. The average institutional ownership in Dyne Therapeutics's industry, Biotech Stocks , is 47.04%, which Dyne Therapeutics exceeds.

Who owns the most shares of Dyne Therapeutics?

Dyne Therapeutics’s largest shareholders are Atlas venture life science advisors (8.02M shares, 9.90%), Fcpm iii services b.v. (7.85M shares, 9.68%), and Blackrock (7.39M shares, 9.11%). Together, they hold 28.69% of Dyne Therapeutics’s total shares outstanding.

Does Blackrock own Dyne Therapeutics?

Yes, BlackRock owns 9.11% of Dyne Therapeutics, totaling 7.39M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 260.69M$. In the last quarter, BlackRock increased its holdings by 2M shares, a 37.05% change.

Who is Dyne Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Dyne Therapeutics’s biggest shareholder by percentage of total assets invested, with 40.83% of its assets in 7.85M Dyne Therapeutics shares, valued at 276.86M$.

Who is the top mutual fund holder of Dyne Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Dyne Therapeutics shares, with 2.59% of its total shares outstanding invested in 2.64M Dyne Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools